Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases-Reference-Cited by-同舟云学术

Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases

Published:2023-09-05 Issue:1 Volume:26 Page:1085-1098
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Diakite Ibrahim¹^ORCID,Nguyen Sylvi²,Sabale Ugne³^ORCID,Pavelyev Andrew¹,Saxena Kunal⁴^ORCID,Tajik Athar Ali²,Wang Wei¹,Palmer Cody¹

Affiliation:

1. Health Economic and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA

2. MSD, Oslo, Norway

3. Center for Observational and Real-World Evidence, MSD, Stockholm, Sweden

4. Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, USA

Funder

Merck

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2250194

Reference51 articles.

1. Global Burden of Human Papillomavirus and Related Diseases

2. Worldwide burden of cancer attributable to HPV by site, country and HPV type

3. Systematic review of the incidence and prevalence of genital warts

4. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis

5. From the monovalent to the nine-valent HPV vaccine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in the Netherlands: a data-driven analysis;2023-12-29

2. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Expert Review of Pharmacoeconomics & Outcomes Research;2023-12-21

3. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Journal of Medical Economics;2023-12-20

4. What to expect in 2024: important health economics and outcomes research (HEOR) trends;Current Medical Research and Opinion;2023-12-20

5. What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends;ClinicoEconomics and Outcomes Research;2023-12